openPR Logo
Press release

Influenza Medication Market Overview by Recent Opportunities, Growth Size, Regional Analysis and Forecasts to 2027

03-16-2022 09:11 AM CET | Health & Medicine

Press release from: Orion Market Research

The global influenza medication market is expected to grow at a significant CAGR during the forecast period (2021-2027). Over the last few decades, the number of severe and life-threatening infectious diseases has increased across the globe. There are various kinds of influenza, which have exhibited a steady increase in occurrence globally. In October 2019, there were 9.7 million influenza cases in the US, according to the Centers for Disease Control and Prevention (CDC). This, in turn, is driving the growth of the market.

The major companies operating in the industry are highly inclined towards the adoption of different growth strategies including partnerships and collaborations, mergers and acquisitions, geographical expansion, and new product launches to remain competitive in the marketplace. For instance, in October 2019, Xofluza (Baloxavir Marboxil) was approved by the FDA for people who are at a high risk of suffering from influenza-related complications. Shionogi & Co., Ltd. stated in October 2019 that a supplemental New Drug Application (sNDA) for Xofluza (baloxavir marboxil) for the postexposure prophylaxis of influenza virus infection had been filed in Japan. Further, Shionogi & Co., Ltd. announced in August 2019 that Xofluza (Baloxavir Marboxil) 20mg tablets have been approved in Taiwan for the treatment of influenza types A and B in individuals over the age of 12. Xofluza is a first-in-class, single-dose oral drug with a new mechanism of action that inhibits polymerase acidic endonuclease, a viral replication enzyme.

To Request a Sample of our Report on Influenza Medication Market: https://www.omrglobal.com/request-sample/influenza-medication-market

In November, 2020, Shionogi & Co., Ltd. announced that F. Hoffmann-La Roche Ltd., which holds global rights to Xofluza except in Japan and Taiwan, has received FDA approval for a supplemental New Drug Application (sNDA) for Xofluza (baloxavir marboxil) as a treatment to prevent influenza in people 12 years of age and older following contact with someone who has influenza (known as post-exposure prophylaxis). In November 2020, Roche announced that the FDA has granted a supplemental New Drug Application (sNDA) for Xofluza (baloxavir marboxil) as a therapy to prevent influenza in patients aged 12 and up who have been exposed to influenza (known as post-exposure prophylaxis).

Market Coverage

• The market number available for - 2020-2027

• Base year- 2020

• Forecast period- 2021-2027

Segment Covered-

· By Product

· By Distribution Channel

Regions covered-

· North America

· Europe

· Asia-Pacific

· Rest of the World

Competitive Landscape: CSL Ltd., F. Hoffmann-La Roche Ltd., and GlaxoSmithKline plc, among others.

(Get 15% Discount on Buying this Report)

A full Report of Influenza Medication Market is Available @ https://www.omrglobal.com/industry-reports/influenza-medication-market

Global Influenza Medication Market Report by Segment

By Product

• Baloxavir (Marboxil)

• Zanamivir

• Oseltamivir

• Peramivir

• Amantadine

• Other (Rimantadine)

By Distribution Channel

• Hospitals

• Clinics

• Pharmacies

• Others

Global Influenza Medication Market Report by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

· Latin America

· Middle East & Africa

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Influenza Medication Market Overview by Recent Opportunities, Growth Size, Regional Analysis and Forecasts to 2027 here

News-ID: 2579688 • Views:

More Releases from Orion Market Research

Eggshell Membrane Market Set to Witness Significant Growth by 2033 | Eggnovations LLC (US), Park Premium Ingredients (US)
Eggshell Membrane Market Set to Witness Significant Growth by 2033 | Eggnovation …
The global Eggshell Membrane Market was valued at approximately USD 173.78 million in 2024, and is projected to reach USD 396.55 million by 2033, growing at a compound annual growth rate (CAGR) of 9.6% from 2025 to 2033. Eggshell Membrane Market Overview The Eggshell Membrane Market is experiencing significant growth, driven by increasing consumer awareness of its health benefits, particularly in joint health and skin care. This natural biopolymer, rich in proteins
Printable Solar Cells Market Set to Witness Significant Growth by 2033 | Armor Group, Dyesol Ltd (Greatcell Solar), Eight19 Ltd, Toshiba Corporation
Printable Solar Cells Market Set to Witness Significant Growth by 2033 | Armor G …
The global Printable Solar Cells Market was valued at approximately USD 1.2 billion in 2024, and is projected to reach USD 4.8 billion by 2033, exhibiting a strong compound annual growth rate (CAGR) of 16.7% from 2025 to 2033. Printable Solar Cells Market Overview The Printable Solar Cells Market is on a rapid upward trajectory, led by rising demand for flexible, lightweight, and cost-effective energy solutions. Printable photovoltaic technologies-including organic, perovskite,
Sales Enablement Software Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Sales Enablement Software Market Size Analysis, Competitive Insights, Leading Pl …
The Sales Enablement Software Market was valued at approximately USD 3.4 billion in 2024 and is projected to reach around USD 13.1 billion by 2033, growing at a compound annual growth rate (CAGR) of 14.7% from 2025 to 2033. Sales Enablement Software Market Overview The Sales Enablement Software Market is experiencing significant growth, driven by the increasing need for businesses to enhance their sales processes and improve team performance. These platforms
Feed management software Market Set to Witness Significant Growth by 2033 | Prairie Systems, Dairy Records Management Systems (DRMS)
Feed management software Market Set to Witness Significant Growth by 2033 | Prai …
The global Feed Management Software Market was estimated to be around USD 0.6 billion in 2024, and is projected to reach approximately USD 1.2 billion by 2033, growing at a compound annual growth rate (CAGR) of about 7.5% from 2025 to 2033. Feed Management Software Market Overview The Feed Management Software Market is expanding steadily as the agriculture and livestock industries shift toward digital transformation to optimize feed formulation and reduce

All 5 Releases


More Releases for Xofluza

Influenza A Market: Epidemiology, Therapies, Companies, DelveInsight | Cidara Th …
Influenza A therapies, such as XOFLUZA, RAPIVAB, FLUAD QUADRIVALENT, mRNA-1010, CD388, Flu Pandemic mRNA (GSK4382276A), CC-42344, and others, are expected to boost the Influenza A Market in the upcoming years. DelveInsight has launched a new report on "Influenza A - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Influenza A, historical and forecasted epidemiology as well as the Influenza A market trends in the United States,
Influenza Medication Market is Anticipated to Increase at a Stable CAGR over the …
Influenza medication market is expected to grow at a significant CAGR during the forecast period.  Over the last few decades, the number of severe and life-threatening infectious diseases has increased across the globe. There are various kinds of influenza, which have exhibited a steady increase in occurrence globally. In October 2019, there were 9.7 million influenza cases in the US, according to the Centers for Disease Control and Prevention (CDC).
Rising Demand for Flu Shots Market Key Players, Growth Analysis during 2021-2027
The global flu shots market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factor that is likely to fuel the growth of the market includes an increase in the prevalence of flu epidemics and seasonal outbreaks. The viral infection which occurs due to flu in the respiratory system is referred to as influenza. The influenza virus travels through respiratory droplets and is contagious.
Global Pediatric Drugs Market Emerging Trend, Top Companies, Industry Demand, Bu …
The global pediatric drug market is projected to exhibit considerable growth during the forecast period (2019-2025). The high prevalence of the pediatric disorder, the rapid increase in the R&D activities related to the drug development process for the treatment of this disorder by the key players operating is a major factor anticipated to fuel the pediatric drug market during the forecast period. Novartis International AG, Genetech, Inc., Medimmune LLC, Johnson
Bird Flu Treatment Market In-deep Analysis and Latest Clinical Advanced Treatmen …
Latest Industry Research Report On global Bird Flu Treatment Market Research Report 2020 in-depth analysis of the market state and also the competitive landscape globally. The Bird Flu Treatment market report provides information regarding market size, share, trends, growth, cost structure, global market competition landscape, market drivers, challenges and opportunity, capacity, revenue and forecast 2026. This report also includes the overall and comprehensive study of the Bird Flu Treatment market with
Antibody-drug Conjugates Market Survey Report 2020 Along with Statistics, Foreca …
The Antibody-drug Conjugates Market Perspective, Comprehensive Analysis along with Major Segments and Forecast, 2019-2025. The Antibody-drug Conjugates market report is a valuable source of data for business strategists. It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; cost, revenue, demands and supply data (as applicable). Report explores the current outlook in global and key regions from the perspective of players,